PROGRESS OF DEVELOPMENT
临床试验三期以后的公开信息
药品 | 剂型 | 特性 | 适应症 | 状态(地区) |
---|---|---|---|---|
Difluprednate | Eye drop | Corticosteroids | inflammation associated with ocular surgery, Uveitis | Approved (Russia) |
SJP-0132 | Eye drop | Novel mechanism of action | Dry eye | P3(Japan) |
SJP-0135 | Eye drop | Fixed combination | Glaucoma | P3(Japan) |
SJP-0008 | Oral tablet | Novel mechanism of action | Central Retinal Artery Occlusion (CRAO) | P3(Japan) |